摘要
随着我国医药体制政策改革的不断深入,医药行业的并购重组日趋活跃,不仅符合客观规律,并有着强大的生命力和良好的发展前景。本文对近10年医药行业海内外并购的现状、特点、发展机遇和风险以及发展态势进行浅析,并提出优化并购策略的建议,以期对我国医药企业海内外并购及国家相关政策的制定提供参考。
With the reform of China's pharmaceutical system going deeper,reorganization of mergers and acquisitions of the pharmaceutical industry is becoming increasingly active.It is not only in accordance with the objective laws,but also has strong vitality and good development prospects.This paper analyzes the present situation,characteristics,development opportunities and risks of domestic and foreign mergers and acquisitions in the pharmaceutical industry in the last ten years,and puts forward some suggestions to optimize the merger strategy,so as to provide reference for the domestic and foreign mergers and acquisitions of Chinese pharmaceutical enterprises and the formulation of relevant national policies.
作者
方中坚
王彩依
沈晨
樊玉录
陈李平
王译
邵蓉
邵明立
FANG Zhong-jian;WANG Cai-yi;SHEN Chen;FAN Yu-lu;CHEN Li-ping;WANG Yi;SHAO Rong;SHAO Ming-li(School of International Pharmaceutical Business,China Pharmaceutical University College of Pharmacy,Nanjing 211198,China;Shanghai University of Medicine&Health Sciences,Shanghai 201318,China;School of Pharmacy,Shanghai Jiao Tong University,Shanghai 200240,China;Health School Affiliated to SUMHS,Shanghai 200237,China;Yunnan Baiyao Group Health Products Co.,Ltd.,Kunming 650217,China)
出处
《中国新药杂志》
CAS
CSCD
北大核心
2023年第15期1503-1506,共4页
Chinese Journal of New Drugs
基金
上海市教委教师发展工程产学研践习项目-上海交通大学(A1-2601-19-311219)。
关键词
医药行业
并购
行业分析
战略管理
pharmaceutical industry
mergers and acquisitions
industry analysis
strategic management
